A detailed history of Invesco Ltd. transactions in Argenx Se stock. As of the latest transaction made, Invesco Ltd. holds 433,516 shares of ARGX stock, worth $246 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
433,516
Previous 201,472 115.17%
Holding current value
$246 Million
Previous $86.6 Million 171.36%
% of portfolio
0.05%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$434.22 - $551.9 $101 Million - $128 Million
232,044 Added 115.17%
433,516 $235 Million
Q2 2024

Aug 13, 2024

SELL
$356.01 - $451.55 $77.5 Million - $98.3 Million
-217,683 Reduced 51.93%
201,472 $86.6 Million
Q1 2024

May 14, 2024

SELL
$356.95 - $413.29 $6.1 Million - $7.06 Million
-17,078 Reduced 3.91%
419,155 $165 Million
Q4 2023

Feb 12, 2024

BUY
$338.91 - $506.01 $1.85 Million - $2.76 Million
5,446 Added 1.26%
436,233 $166 Million
Q3 2023

Nov 13, 2023

BUY
$369.35 - $548.43 $126 Million - $187 Million
340,482 Added 377.04%
430,787 $212 Million
Q2 2023

Aug 11, 2023

BUY
$360.14 - $422.58 $11.9 Million - $14 Million
33,036 Added 57.69%
90,305 $35.2 Million
Q1 2023

May 12, 2023

SELL
$334.23 - $403.65 $5.2 Million - $6.28 Million
-15,558 Reduced 21.36%
57,269 $21.3 Million
Q4 2022

Feb 13, 2023

BUY
$342.17 - $402.31 $8.5 Million - $10 Million
24,847 Added 51.79%
72,827 $27.6 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $4.84 Million - $5.58 Million
14,106 Added 41.64%
47,980 $16.9 Million
Q2 2022

Aug 15, 2022

BUY
$269.58 - $378.88 $45,289 - $63,651
168 Added 0.5%
33,874 $12.8 Million
Q1 2022

May 16, 2022

SELL
$254.45 - $351.06 $4.16 Million - $5.74 Million
-16,364 Reduced 32.68%
33,706 $10.6 Million
Q4 2021

Feb 14, 2022

BUY
$272.01 - $353.03 $417,535 - $541,901
1,535 Added 3.16%
50,070 $17.5 Million
Q3 2021

Nov 15, 2021

BUY
$295.0 - $350.58 $200,305 - $238,043
679 Added 1.42%
48,535 $14.7 Million
Q2 2021

Aug 17, 2021

SELL
$257.11 - $319.92 $58.7 Million - $73.1 Million
-228,339 Reduced 82.67%
47,856 $14.4 Million
Q1 2021

May 17, 2021

BUY
$268.3 - $380.31 $8.55 Million - $12.1 Million
31,854 Added 13.04%
276,195 $76.1 Million
Q4 2020

Feb 16, 2021

SELL
$248.13 - $308.36 $14.8 Million - $18.4 Million
-59,756 Reduced 19.65%
244,341 $71.9 Million
Q3 2020

Nov 16, 2020

SELL
$215.51 - $272.51 $13 Million - $16.4 Million
-60,165 Reduced 16.52%
304,097 $79.8 Million
Q2 2020

Aug 14, 2020

BUY
$127.44 - $232.72 $46.4 Million - $84.8 Million
364,262 New
364,262 $82 Million
Q4 2019

Feb 14, 2020

SELL
$106.59 - $164.21 $343,326 - $528,920
-3,221 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$113.31 - $150.51 $1.16 Million - $1.54 Million
-10,220 Reduced 76.04%
3,221 $367,000
Q2 2019

Aug 14, 2019

SELL
$115.0 - $141.58 $2.53 Million - $3.11 Million
-21,960 Reduced 62.03%
13,441 $1.9 Million
Q1 2019

May 15, 2019

SELL
$98.85 - $134.59 $1.49 Million - $2.03 Million
-15,070 Reduced 29.86%
35,401 $4.42 Million
Q4 2018

Feb 14, 2019

BUY
$63.81 - $109.82 $3.22 Million - $5.54 Million
50,471 New
50,471 $4.85 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.4B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.